Chester County News and Community Website
PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) announced that the U.S. Food and Drug Administration (FDA) has issued a Refusal to File (RTF) letter for its supplemental …
Harmony Biosciences Faces Regulatory Setback, Outlines Future Plans for Pitolisant Read More PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced plans to release its fourth quarter and full year 2024 financial results on Tuesday, February 25, 2025, ahead …
Harmony Biosciences to Announce Q4 & Full Year 2024 Results on February 25, 2025 Read More PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced robust preliminary net product revenues for the fourth quarter and full year of 2024, with figures reaching $201 million …
Harmony Biosciences Reports Strong Revenue Growth and Outlines Ambitious 2025 Strategy Read More PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has confirmed its participation in the 43rd Annual J.P. Morgan Healthcare Conference, set to take place in San Francisco, California. Jeffrey …
Harmony Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference Read More PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced that its management team will participate in a fireside chat at the Oppenheimer Movers in Rare Disease Summit, scheduled …
Harmony Biosciences to Join Fireside Chat at Oppenheimer Rare Disease Summit Read More PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) announced that Harmony’s management team will participate in several upcoming investor conferences to discuss their progress and future plans. These …
Harmony Biosciences Hits the Stage: Engaging Investors at Top 2024 Conferences Read More
PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) announced a remarkable achievement with $186.0 million in net revenue for the third quarter ending September 30, 2024. This milestone …
Harmony Biosciences Reports Record Revenue and Plans Expansion in CNS Treatments Read More PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) is set to showcase its promising late-stage pipeline during an Investor Day event scheduled for October 1 in New York City. …
Harmony Biosciences to Unveil Promising Late-Stage Pipeline at Investor Day Read More PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) will actively participate in two major investor conferences this September.
Harmony Biosciences Set to Engage at Key Investor Conferences Read More PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) reported a 29% increase in net revenue for the quarter ended June 30, 2024. The company highlighted progress in its …
Harmony Biosciences Reports Q2 Growth and Expands Pipeline Read More